These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 3297439)
1. Behavior of beta 2-microglobulin in patients with chronic renal failure undergoing hemodialysis, hemodiafiltration and continuous ambulatory peritoneal dialysis (CAPD). Blumberg A; Bürgi W Clin Nephrol; 1987 May; 27(5):245-9. PubMed ID: 3297439 [TBL] [Abstract][Full Text] [Related]
2. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function. McCarthy JT; Williams AW; Johnson WJ J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998 [TBL] [Abstract][Full Text] [Related]
3. [Changes in the beta 2-microglobulin level during hemodialysis]. Nikitinskaia LP; Stetsiuk EA; Iarmolinskiĭ IS; Barinov AV; Kon'kova TA Urol Nefrol (Mosk); 1990; (5):29-31. PubMed ID: 2264202 [TBL] [Abstract][Full Text] [Related]
4. [What does circulating beta 2 microglobulin signify in uremic patients on maintenance dialysis?]. Assounga A; Canaud B; Flavier JL; Slingeneyer A; Robinet-Lévy M; Aznar R; Mion C Nephrologie; 1987; 8(6):301-6. PubMed ID: 3330579 [TBL] [Abstract][Full Text] [Related]
5. Dialysis arthropathy, beta 2-microglobulin and the effect of dialyser membrane. Sethi D; Gower PE Nephrol Dial Transplant; 1988; 3(6):768-72. PubMed ID: 3147418 [TBL] [Abstract][Full Text] [Related]
6. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients. Zehnder C; Gutzwiller JP; Renggli K Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310 [TBL] [Abstract][Full Text] [Related]
7. [The analysis of plasma beta 2-microglobulin concentration in patients with chronic renal failure treated by hemodialysis]. Król Z; Morawska Z Pediatr Pol; 1996 Feb; 71(2):121-5. PubMed ID: 8966077 [TBL] [Abstract][Full Text] [Related]
8. A circulating beta 2-microglobulin intermediate in hemodialysis patients. Uji Y; Motomiya Y; Ando Y Nephron Clin Pract; 2009; 111(3):c173-81. PubMed ID: 19194107 [TBL] [Abstract][Full Text] [Related]
9. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. Cheung AK; Rocco MV; Yan G; Leypoldt JK; Levin NW; Greene T; Agodoa L; Bailey J; Beck GJ; Clark W; Levey AS; Ornt DB; Schulman G; Schwab S; Teehan B; Eknoyan G J Am Soc Nephrol; 2006 Feb; 17(2):546-55. PubMed ID: 16382021 [TBL] [Abstract][Full Text] [Related]
10. [Serum beta 2-microglobulin concentration and its removal in patients treated with continuous ambulatory peritoneal dialysis]. Kubo H; Kawaguchi Y; Aizawa S; Morita T; Nakayama M; Wakabayashi Y; Watanabe S; Ogawa A; Sakai O Nihon Jinzo Gakkai Shi; 1990 Apr; 32(4):419-26. PubMed ID: 2198365 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis]. Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852 [TBL] [Abstract][Full Text] [Related]
12. Beta 2 microglobulin in CAPD. Montenegro J; Martínez I; Saracho R; González R Adv Perit Dial; 1992; 8():369-72. PubMed ID: 1361825 [TBL] [Abstract][Full Text] [Related]
13. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study. Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097 [TBL] [Abstract][Full Text] [Related]
14. Beta-2 microglobulin in patients on peritoneal dialysis and hemodialysis. Scalamogna A; Imbasciati E; De Vecchi A; Castelnovo C; Pagliari B; De Cristofaro V; Ponticelli C Perit Dial Int; 1989; 9(1):37-40. PubMed ID: 2488178 [TBL] [Abstract][Full Text] [Related]
15. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial. Pellicano R; Polkinghorne KR; Kerr PG Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807 [TBL] [Abstract][Full Text] [Related]
16. [Significance of serum levels of beta-2-microglobulin in dialysis patients]. Baldrati L; Baldrati L; Delvecchio C; Capponcini C; Docci D; Turci F; Feletti C Recenti Prog Med; 1990 Sep; 81(9):561-3. PubMed ID: 2263750 [TBL] [Abstract][Full Text] [Related]
17. The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients. Erten Y; Ebinç FA; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S Ren Fail; 2008; 30(6):617-23. PubMed ID: 18661412 [TBL] [Abstract][Full Text] [Related]
18. Peritoneal clearance of leptin in continuous ambulatory peritoneal dialysis. Arkouche W; Juillard L; Delawari E; Lasne Y; Combarnous F; Sibaï-Galland R; Traeger J; Laville M; Fouque D Am J Kidney Dis; 1999 Nov; 34(5):839-44. PubMed ID: 10561139 [TBL] [Abstract][Full Text] [Related]
19. [Behavior of beta 2-microglobulin in patients undergoing blood purification]. Hou FF Zhonghua Nei Ke Za Zhi; 1990 Jun; 29(6):353-6, 383. PubMed ID: 2269036 [TBL] [Abstract][Full Text] [Related]